Jarosch, A., Reißfelder, C., Weitz, J., & Krause, M. (2018). Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer. OncoImmunology, 7(2), . https://doi.org/10.1080/2162402X.2017.1393133
Chicago-Zitierstil (17. Ausg.)Jarosch, Armin, Christoph Reißfelder, Jürgen Weitz, und Mechthild Krause. "Neoadjuvant Radiochemotherapy Decreases the Total Amount of Tumor Infiltrating Lymphocytes, but Increases the Number of CD8+/Granzyme B+ (GrzB) Cytotoxic T-cells in Rectal Cancer." OncoImmunology 7, no. 2 (2018). https://doi.org/10.1080/2162402X.2017.1393133.
MLA-Zitierstil (9. Ausg.)Jarosch, Armin, et al. "Neoadjuvant Radiochemotherapy Decreases the Total Amount of Tumor Infiltrating Lymphocytes, but Increases the Number of CD8+/Granzyme B+ (GrzB) Cytotoxic T-cells in Rectal Cancer." OncoImmunology, vol. 7, no. 2, 2018, https://doi.org/10.1080/2162402X.2017.1393133.